Halting Retrograde Transport Excludes ErbB-2 From the Nucleus Abrogating Tumor Growth in Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) refers to a subtype of tumors with poor prognosis, devoid of hormone receptors and of membrane overexpression or gene amplification of ErbB-2. Due to its molecular heterogeneity, TNBC represents a major clinical challenge. In this regard, clinical biomarkers and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Endocr Soc
Auteurs principaux: Madera, Santiago, Izzo, Franco, Chervo, María Florencia, Dupont, Agustina, Chiauzzi, Violeta Alicia, Montero, Diego, Deamicis, Agustina Roldán, Proietti, Cecilia Jazmín, Schillaci, Roxana, Elizalde, Patricia Virginia, Russo, Rosalia Ines Cordo
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
Tumor Biology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089291/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.2087
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires